News
Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...
Windtree Therapeutics, a Nasdaq listed biotechnology company, has plans to raise up to $200 million to build a treasury of ...
Biotech stories typically tread a very fine line between promise and pressure. Sometimes a company that’s been a pioneer in ...
Sarepta Therapeutics announces layoffs of 493 employees, including 80 in Franklin County, amid restructuring efforts and ...
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin ...
Some of the most high-profile acquisitions in recent years have involved women-fronted biotechs. BioSpace reviews five of the ...
Jasper Therapeutics started the year with 64 full-time employees and a robust valuation of more than $320 million. Just seven ...
Windtree Therapeutics plans to raise $200M to build a BNB treasury, becoming the first Nasdaq-listed firm to adopt BNB as a strategic reserve asset.Ask ChatGPT ...
Clearside Biomedical will divert all employees to a consulting status and halt research-and-development, allowing the eye-care biotechnology firm to conserve cash during a search for a deal or other ...
Sonnet BioTherapeutics pivots to crypto with $888M deal, forming Hyperliquid Strategies Inc. to hold 12.6M HYPE tokens.
Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results